KTTA Pasithea Therapeutics Corp. - Common Stock

NASDAQ · Biotechnology
$0.49
Price · Aug 19, 2026

KTTA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.49
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$0 – $2

KTTA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
KTTA
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
KTTA
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
KTTA
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
KTTA
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
KTTA
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
KTTA
Peer Median

KTTA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-20
Median target $3.00 +510.9%
Mean target $3.00 +510.9%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.54%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.12 $-0.46 0.34%
Dec. 31, 2025 $-0.79 $-0.18 -0.61%
Dec. 31, 2024 $-2.41
March 31, 2022 $-1.40 $-0.41 -0.99%
Dec. 31, 2021 $2.40 $-1.02 3.4%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
KTTA
KALA $15M -0.2 -1423.8%
TPST $14M -0.5 -319.3%
BCDA $13M -87.8% 1660.5%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 26 filers · $9.1M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
7 (+4 vs prior Q) 0 (-8 vs prior Q) 8 (+2 vs prior Q) 5 (+3 vs prior Q) +3.1M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
JANUS HENDERSON GROUP PLC $1,564,500 2,100,000 17.19% Shares
Cable Car Capital, LP $1,546,200 3,000,000 16.99% Shares
Stonepine Capital Management, LLC $1,134,637 2,201,468 12.47% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $1,082,340 2,100,000 11.89% Shares
Opaleye Management Inc. $1,056,570 2,050,000 11.61% Shares
AMERIPRISE FINANCIAL INC $960,955 1,864,485 10.56% Shares
Squadron Capital Management LLC $515,400 1,000,000 5.66% Shares
AdvisorShares Investments LLC $483,213 937,550 5.31% Shares
Vivo Capital, LLC $239,904 465,471 2.64% Shares
Persistent Asset Partners Ltd $149,752 290,555 1.65% Shares
XTX Topco Ltd $65,751 127,572 0.72% Shares
VANGUARD CAPITAL MANAGEMENT LLC $65,034 126,279 0.71% Shares
VANGUARD GROUP INC $56,579 43,860 0.62% Shares
GEODE CAPITAL MANAGEMENT, LLC $40,844 79,244 0.45% Shares
RENAISSANCE TECHNOLOGIES LLC $33,810 65,600 0.37% Shares
TWO SIGMA INVESTMENTS, LP $33,071 64,166 0.36% Shares
VANGUARD FIDUCIARY TRUST CO $22,588 43,860 0.25% Shares
NORTHERN TRUST CORP $16,186 31,405 0.18% Shares
Jump Financial, LLC $14,236 27,622 0.16% Shares
UBS Group AG $10,550 20,485 0.12% Shares
Tower Research Capital LLC (TRC) $4,555 8,838 0.05% Shares
Hurley Capital, LLC $3,608 7,000 0.04% Shares
SBI Securities Co., Ltd. $542 1,051 0.01% Shares
BARCLAYS PLC $139 269 0.00% Shares
JPMORGAN CHASE & CO $79 150 0.00% Shares
ROYAL BANK OF CANADA $0 275 0.00% Shares

Company insiders 8 insiders · 4 officers · 5 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Tiago Marques Chief Executive Officer May 1, 2026 A 73,334 1 0 $25,000
Daniel H Schneiderman Chief Financial Officer May 1, 2026 A 26,667 0 0 $0
Kartik Krishnan Chief Medical Officer May 1, 2026 A 0 0 $0
Graeme Martin Currie Chief Development Officer March 1, 2024 A 0 0 $0
Simon Dumesnil Director May 1, 2026 A 35,833 1 0 $25,000
Emer Leahy Director May 1, 2026 A 33,333 0 0 $0
Alfred J Novak Director May 1, 2026 A 3,500 0 0 $0
Lawrence Steinman Director May 1, 2026 A 199,691 1 0 $100,000

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Lawrence Steinman June 8, 2023 Initial filing SEC
Concord IP2 Ltd. (2), Elderhill Corporation (2), David Delaney (2), Leonite Capital LLC (2), Leonite Fund I, LP (2), Avi Geller (2), Camac Partners, LLC (2), Camac Capital, LLC (2), Camac Fund, LP (2), Eric Shahinian (2) ×10 filings Jan. 10, 2023 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS July 15, 2026 Daily